Vaneck Vectors Global Health Leaders ETF (ASX:HLTH)

Assets	57.93M
Expense Ratio	0.45%
PE Ratio	21.42
Dividend (ttm)	0.04
Dividend Yield	0.33%
Ex-Dividend Date	Jul 1, 2026
Payout Frequency	Annual
Payout Ratio	7.14%
1-Year Return	+5.56%

Volume	3,039
Open	11.94
Previous Close	11.93
Day's Range	11.94 - 11.96
52-Week Low	10.50
52-Week High	13.00
Beta	0.34
Holdings	10
Inception Date	Sep 8, 2020

About HLTH

HLTH.AX was created on 2020-09-08 by VanEck. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investment returns before fees and other costs which track the performance of the Reference Index in Australian dollars.

• Asset Class: Equity
• Category: Health Care
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: HLTH
• Provider: VanEck
• Index Tracked: MarketGrader Developed Markets ex-Australia Health Care Index - AUD

Performance

HLTH had a total return of 5.56% in the past year, including dividends. Since the fund's inception, the average annual return has been 3.41%.

Top Holdings

26.92% of assets

Name	Symbol	Weight
Illumina, Inc.	ILMN	3.24%
Halozyme Therapeutics, Inc.	HALO	3.02%
Arrowhead Pharmaceuticals, Inc.	ARWR	2.87%
West Pharmaceutical Services, Inc.	WST	2.72%
argenx SE	ARGX	2.68%
Ypsomed Holding AG	YPSN	2.63%
DexCom, Inc.	DXCM	2.54%
Incyte Corporation	INCY	2.49%
ALTEOGEN Inc.	196170	2.37%
Exelixis, Inc.	EXEL	2.36%

Dividend History

Ex-Dividend	Amount	Pay Date
Jul 1, 2026	0.040 AUD	Jul 27, 2026
Jul 1, 2025	0.020 AUD	Jul 25, 2025
Jul 1, 2024	0.090 AUD	Jul 23, 2024
Jul 3, 2023	0.110 AUD	Jul 25, 2023
Jul 1, 2022	0.060 AUD	Jul 25, 2022
Jul 1, 2021	0.040 AUD	Jul 23, 2021

Data Sources: S&P Global Market Intelligence, Twelve Data, and more

Historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Sep 1, 2026

Data Sources Report a data error